New: NCI-funded clinical trial search
Mednet Logo
CommunityEndocrinology

What are the main differences between TRYNGOLZA and Redemplo?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Endocrinology · Medical University of South Carolina College of Medicine
Answered on

TRYNGOLZA (olesarsen) and Redemplo (plozasiran) both work to reduce apoC-III production, a known inhibitor of LPL activity, thus leading to significant triglyceride lowering. Olezarsen is an antisense oligonucleotide, and plozasirin is an siRNA. Both lower triglycerides by 40-60% and both are FDA-ap...

Join for free or sign in to see the full answer